These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 433969)

  • 1. Studies in porphyria. VIII. Relationship of the 5 alpha-reductive metabolism of steroid hormones to clinical expression of the genetic defect in acute intermittent porphyria.
    Anderson KE; Bradlow HL; Sassa S; Kappas A
    Am J Med; 1979 Apr; 66(4):644-50. PubMed ID: 433969
    [No Abstract]   [Full Text] [Related]  

  • 2. Endocrine-gene interaction in the pathogenesis of acute intermittent porphyria.
    Kappas A; Sassa S; Granick S; Bradlow HL
    Res Publ Assoc Res Nerv Ment Dis; 1974; 53():225-37. PubMed ID: 4612660
    [No Abstract]   [Full Text] [Related]  

  • 3. Induction of a deficiency of steroid delta 4-5 alpha-reductase activity in liver by a porphyrinogenic drug.
    Kappas A; Bradlow HL; Bickers DR; Alvares AP
    J Clin Invest; 1977 Jan; 59(1):159-64. PubMed ID: 830660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies in porphyria. II. Evidence for a deficiency of steroid delta-4-5-alpha-reductase activity in acute intermittent porphyria.
    Bradlow HL; Gillette PN; Gallagher TF; Kappas A
    J Exp Med; 1973 Oct; 138(4):754-63. PubMed ID: 4270345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute intermittent porphyria at 4 months of age].
    Beauvais P; Klein ML; Denave L; Martel C
    Arch Fr Pediatr; 1976 Dec; 33(10):987-92. PubMed ID: 1015983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies in porphyria. I. A defect in the reductive transformation of natural steroid hormones in the hereditary liver disease, acute intermittent porphyria.
    Kappas A; Bradlow HL; Gillette PN; Gallagher TF
    J Exp Med; 1972 Nov; 136(5):1043-53. PubMed ID: 4263649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The enzymopathic nature of porphyria].
    Gajdos A
    Nouv Presse Med; 1976 May; 5(22):1417-22. PubMed ID: 778793
    [No Abstract]   [Full Text] [Related]  

  • 8. A defect of steroid hormone metabolism in acute intermittent porphyria.
    Kappas A; Bradlow HL; Gillette PN; Levere RD; Gallagher TF
    Fed Proc; 1972; 31(4):1293-7. PubMed ID: 4261014
    [No Abstract]   [Full Text] [Related]  

  • 9. A microassay for uroporphyrinogen I synthase, one of three abnormal enzyme activities in acute intermittent porphyria, and its application to the study of the genetics of this disease.
    Sassa S; Granick S; Bickers DR; Bradlow HL; Kappas A
    Proc Natl Acad Sci U S A; 1974 Mar; 71(3):732-6. PubMed ID: 4522787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the porphobilinogen deaminase deficiency in acute intermittent porphyria. Immunologic evidence for heterogeneity of the genetic defect.
    Anderson PM; Reddy RM; Anderson KE; Desnick RJ
    J Clin Invest; 1981 Jul; 68(1):1-12. PubMed ID: 7251856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal steroid hormone metabolism in the genetic liver disease acute intermittent porphyria.
    Kappas A; Bradlow HL; Gillette PN; Gallagher TF
    Ann N Y Acad Sci; 1971 Jul; 179():611-24. PubMed ID: 5285393
    [No Abstract]   [Full Text] [Related]  

  • 12. [Uroporphyrinogen-I-synthetase in erythrocytes in acute intermittent porphyria].
    Iwanov ED; Adjarov D; Tsanev R
    Acta Biol Med Ger; 1977; 36(5-6):801-4. PubMed ID: 602585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocyte uroporphyrinogen-I-synthetase activity in acute intermittent porphyria.
    Wilson JH; van den Berg JW; Brouwers D; Coppens K; van Zellem J
    Neth J Med; 1979; 22(1):13-6. PubMed ID: 418940
    [No Abstract]   [Full Text] [Related]  

  • 14. Prenatal diagnosis of acute intermittent porphyria.
    Sassa S; Kappas A
    N Engl J Med; 1976 Dec; 295(24):1381. PubMed ID: 980088
    [No Abstract]   [Full Text] [Related]  

  • 15. ACUTE INTERMITTENT PORPHYRIA: THE FIRST "OVERPRODUCTION DISEASE" LOCALIZED TO A SPECIFIC ENZYME.
    TSCHUDY DP; PERLROTH MG; MARVER HS; COLLINS A; HUNTER G; RECHCIGL M
    Proc Natl Acad Sci U S A; 1965 Apr; 53(4):841-7. PubMed ID: 14329695
    [No Abstract]   [Full Text] [Related]  

  • 16. Glycine metabolism in acute porphyria.
    RICHARDS FF; SCOTT JJ
    Clin Sci; 1961 Jun; 20():387-400. PubMed ID: 13741260
    [No Abstract]   [Full Text] [Related]  

  • 17. Recurrence risk estimation of acute intermittent porphyria based on analysis of porphobilinogen deaminase activity: a Bayesian approach.
    Bonaïti-Pellié C; Phung L; Nordmann Y
    Am J Med Genet; 1984 Dec; 19(4):755-62. PubMed ID: 6517099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute intermittent porphyria. Detection of asymptomatic carriers of the genetic defect].
    Grandchamp B; Grelier M; Nordmann Y
    Nouv Presse Med; 1975 Jun; 4(24):1801-2. PubMed ID: 1161481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute intermittent porphyria in two patients on anticonvulsant therapy and with normal erythrocyte porphobilinogen deaminase activity.
    Herrick AL; McColl KE; Moore MR; Brodie MJ; Adamson AR; Goldberg A
    Br J Clin Pharmacol; 1989 Apr; 27(4):491-7. PubMed ID: 2497768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal electrolyte and water metabolism in acute intermittent porphyria. The transient inappropriate secretion of antidiuretic hormone.
    HELLMAN ES; TSCHUDY DP; BARTTER FC
    Am J Med; 1962 May; 32():734-46. PubMed ID: 13906281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.